世界のデシタビン市場予測（～2028年）：10Mg剤形、15Mg剤形、25Mg剤形

• 英文タイトル：Global Decitabine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E8783 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

デシタビン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のデシタビンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 デシタビン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・10Mg剤形、15Mg剤形、25Mg剤形 用途別セグメントは次のように区分されます。 ・プライマリMDS、セカンダリMDS 世界のデシタビン市場の主要な市場プレーヤーは以下のとおりです。 ・Johnson & Johnson、Eli Lilly and Company、Pharmachemie B.V.、Otsuka Pharmaceutical、Sandoz、Dr Reddy's Laboratories、Accord Healthcare、Sun Pharmaceutical、Cipla、Lupin、Shandong Xinshidai Pharmaceutical、Hangzhou Zhongmei Huadong Pharmaceutical、ZHENGDA Tianqing Pharmaceutical Group、Jiangsu Aosaikang Pharmaceutical、Jiangsu Haosen Pharmaceutical Group、Lianyungang Jierui Pharmaceutical、Qilu Pharmaceutical Hainan、Lianyungang Runzhong Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、デシタビン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なデシタビンメーカーの企業概要、2019年～2022年までのデシタビンの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なデシタビンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別デシタビンの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのデシタビンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのデシタビン市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびデシタビンの産業チェーンを掲載しています。 ・第13、14、15章では、デシタビンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Johnson & Johnson、Eli Lilly and Company、Pharmachemie B.V.、Otsuka Pharmaceutical、Sandoz、Dr Reddy's Laboratories、Accord Healthcare、Sun Pharmaceutical、Cipla、Lupin、Shandong Xinshidai Pharmaceutical、Hangzhou Zhongmei Huadong Pharmaceutical、ZHENGDA Tianqing Pharmaceutical Group、Jiangsu Aosaikang Pharmaceutical、Jiangsu Haosen Pharmaceutical Group、Lianyungang Jierui Pharmaceutical、Qilu Pharmaceutical Hainan、Lianyungang Runzhong Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：10Mg剤形、15Mg剤形、25Mg剤形 ・用途別分析2017年-2028年：プライマリMDS、セカンダリMDS ・デシタビンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・デシタビンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・デシタビンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・デシタビンの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・デシタビンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Decitabine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Decitabine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Primary MDS accounting for % of the Decitabine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 10 Mg Dosage Forms segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Decitabine include Johnson & Johnson, Eli Lilly and Company, Pharmachemie B.V., Otsuka Pharmaceutical, and Sandoz, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Decitabine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10 Mg Dosage Forms
15 Mg Dosage Forms
25 Mg Dosage Forms
Market segment by Application can be divided into
Primary MDS
Secondary MDS
The key market players for global Decitabine market are listed below:
Johnson & Johnson
Eli Lilly and Company
Pharmachemie B.V.
Otsuka Pharmaceutical
Sandoz
Dr Reddy’s Laboratories
Accord Healthcare
Sun Pharmaceutical
Cipla
Lupin
Shandong Xinshidai Pharmaceutical
Hangzhou Zhongmei Huadong Pharmaceutical
ZHENGDA Tianqing Pharmaceutical Group
Jiangsu Aosaikang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Lianyungang Jierui Pharmaceutical
Qilu Pharmaceutical Hainan
Lianyungang Runzhong Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Decitabine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Decitabine, with price, sales, revenue and global market share of Decitabine from 2019 to 2022.
Chapter 3, the Decitabine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Decitabine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Decitabine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Decitabine.
Chapter 13, 14, and 15, to describe Decitabine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Decitabine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Decitabine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 10 Mg Dosage Forms
1.2.3 15 Mg Dosage Forms
1.2.4 25 Mg Dosage Forms
1.3 Market Analysis by Application
1.3.1 Overview: Global Decitabine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Primary MDS
1.3.3 Secondary MDS
1.4 Global Decitabine Market Size & Forecast
1.4.1 Global Decitabine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Decitabine Sales in Volume (2017-2028)
1.4.3 Global Decitabine Price (2017-2028)
1.5 Global Decitabine Production Capacity Analysis
1.5.1 Global Decitabine Total Production Capacity (2017-2028)
1.5.2 Global Decitabine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Decitabine Market Drivers
1.6.2 Decitabine Market Restraints
1.6.3 Decitabine Trends Analysis
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Decitabine Product and Services
2.1.4 Johnson & Johnson Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business
2.2.3 Eli Lilly and Company Decitabine Product and Services
2.2.4 Eli Lilly and Company Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pharmachemie B.V.
2.3.1 Pharmachemie B.V. Details
2.3.2 Pharmachemie B.V. Major Business
2.3.3 Pharmachemie B.V. Decitabine Product and Services
2.3.4 Pharmachemie B.V. Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Otsuka Pharmaceutical
2.4.1 Otsuka Pharmaceutical Details
2.4.2 Otsuka Pharmaceutical Major Business
2.4.3 Otsuka Pharmaceutical Decitabine Product and Services
2.4.4 Otsuka Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sandoz
2.5.1 Sandoz Details
2.5.2 Sandoz Major Business
2.5.3 Sandoz Decitabine Product and Services
2.5.4 Sandoz Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Dr Reddy’s Laboratories
2.6.1 Dr Reddy’s Laboratories Details
2.6.2 Dr Reddy’s Laboratories Major Business
2.6.3 Dr Reddy’s Laboratories Decitabine Product and Services
2.6.4 Dr Reddy’s Laboratories Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Accord Healthcare
2.7.1 Accord Healthcare Details
2.7.2 Accord Healthcare Major Business
2.7.3 Accord Healthcare Decitabine Product and Services
2.7.4 Accord Healthcare Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sun Pharmaceutical
2.8.1 Sun Pharmaceutical Details
2.8.2 Sun Pharmaceutical Major Business
2.8.3 Sun Pharmaceutical Decitabine Product and Services
2.8.4 Sun Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Decitabine Product and Services
2.9.4 Cipla Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Lupin
2.10.1 Lupin Details
2.10.2 Lupin Major Business
2.10.3 Lupin Decitabine Product and Services
2.10.4 Lupin Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Shandong Xinshidai Pharmaceutical
2.11.1 Shandong Xinshidai Pharmaceutical Details
2.11.2 Shandong Xinshidai Pharmaceutical Major Business
2.11.3 Shandong Xinshidai Pharmaceutical Decitabine Product and Services
2.11.4 Shandong Xinshidai Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Hangzhou Zhongmei Huadong Pharmaceutical
2.12.1 Hangzhou Zhongmei Huadong Pharmaceutical Details
2.12.2 Hangzhou Zhongmei Huadong Pharmaceutical Major Business
2.12.3 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Product and Services
2.12.4 Hangzhou Zhongmei Huadong Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 ZHENGDA Tianqing Pharmaceutical Group
2.13.1 ZHENGDA Tianqing Pharmaceutical Group Details
2.13.2 ZHENGDA Tianqing Pharmaceutical Group Major Business
2.13.3 ZHENGDA Tianqing Pharmaceutical Group Decitabine Product and Services
2.13.4 ZHENGDA Tianqing Pharmaceutical Group Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Jiangsu Aosaikang Pharmaceutical
2.14.1 Jiangsu Aosaikang Pharmaceutical Details
2.14.2 Jiangsu Aosaikang Pharmaceutical Major Business
2.14.3 Jiangsu Aosaikang Pharmaceutical Decitabine Product and Services
2.14.4 Jiangsu Aosaikang Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Jiangsu Haosen Pharmaceutical Group
2.15.1 Jiangsu Haosen Pharmaceutical Group Details
2.15.2 Jiangsu Haosen Pharmaceutical Group Major Business
2.15.3 Jiangsu Haosen Pharmaceutical Group Decitabine Product and Services
2.15.4 Jiangsu Haosen Pharmaceutical Group Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Lianyungang Jierui Pharmaceutical
2.16.1 Lianyungang Jierui Pharmaceutical Details
2.16.2 Lianyungang Jierui Pharmaceutical Major Business
2.16.3 Lianyungang Jierui Pharmaceutical Decitabine Product and Services
2.16.4 Lianyungang Jierui Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Qilu Pharmaceutical Hainan
2.17.1 Qilu Pharmaceutical Hainan Details
2.17.2 Qilu Pharmaceutical Hainan Major Business
2.17.3 Qilu Pharmaceutical Hainan Decitabine Product and Services
2.17.4 Qilu Pharmaceutical Hainan Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Lianyungang Runzhong Pharmaceutical
2.18.1 Lianyungang Runzhong Pharmaceutical Details
2.18.2 Lianyungang Runzhong Pharmaceutical Major Business
2.18.3 Lianyungang Runzhong Pharmaceutical Decitabine Product and Services
2.18.4 Lianyungang Runzhong Pharmaceutical Decitabine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Decitabine Breakdown Data by Manufacturer
3.1 Global Decitabine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Decitabine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Decitabine
3.4 Market Concentration Rate
3.4.1 Top 3 Decitabine Manufacturer Market Share in 2021
3.4.2 Top 6 Decitabine Manufacturer Market Share in 2021
3.5 Global Decitabine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Decitabine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Decitabine Market Size by Region
4.1.1 Global Decitabine Sales in Volume by Region (2017-2028)
4.1.2 Global Decitabine Revenue by Region (2017-2028)
4.2 North America Decitabine Revenue (2017-2028)
4.3 Europe Decitabine Revenue (2017-2028)
4.4 Asia-Pacific Decitabine Revenue (2017-2028)
4.5 South America Decitabine Revenue (2017-2028)
4.6 Middle East and Africa Decitabine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Decitabine Sales in Volume by Type (2017-2028)
5.2 Global Decitabine Revenue by Type (2017-2028)
5.3 Global Decitabine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Decitabine Sales in Volume by Application (2017-2028)
6.2 Global Decitabine Revenue by Application (2017-2028)
6.3 Global Decitabine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Decitabine Sales by Type (2017-2028)
7.2 North America Decitabine Sales by Application (2017-2028)
7.3 North America Decitabine Market Size by Country
7.3.1 North America Decitabine Sales in Volume by Country (2017-2028)
7.3.2 North America Decitabine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Decitabine Sales by Type (2017-2028)
8.2 Europe Decitabine Sales by Application (2017-2028)
8.3 Europe Decitabine Market Size by Country
8.3.1 Europe Decitabine Sales in Volume by Country (2017-2028)
8.3.2 Europe Decitabine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Decitabine Sales by Type (2017-2028)
9.2 Asia-Pacific Decitabine Sales by Application (2017-2028)
9.3 Asia-Pacific Decitabine Market Size by Region
9.3.1 Asia-Pacific Decitabine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Decitabine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Decitabine Sales by Type (2017-2028)
10.2 South America Decitabine Sales by Application (2017-2028)
10.3 South America Decitabine Market Size by Country
10.3.1 South America Decitabine Sales in Volume by Country (2017-2028)
10.3.2 South America Decitabine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Decitabine Sales by Type (2017-2028)
11.2 Middle East & Africa Decitabine Sales by Application (2017-2028)
11.3 Middle East & Africa Decitabine Market Size by Country
11.3.1 Middle East & Africa Decitabine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Decitabine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Decitabine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Decitabine
12.3 Decitabine Production Process
12.4 Decitabine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Decitabine Typical Distributors
13.3 Decitabine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---